115 related articles for article (PubMed ID: 7955606)
61. Diagnosing late onset rheumatoid arthritis, polymyalgia rheumatica, and temporal arteritis in patients presenting with polymyalgic symptoms. A prospective longterm evaluation.
Pease CT; Haugeberg G; Morgan AW; Montague B; Hensor EM; Bhakta BB
J Rheumatol; 2005 Jun; 32(6):1043-6. PubMed ID: 15940765
[TBL] [Abstract][Full Text] [Related]
62. RANTES gene polymorphism in polymyalgia rheumatica, giant cell arteritis and rheumatoid arthritis.
Makki RF; al Sharif F; González-Gay MA; García-Porrúa C; Ollier WE; Hajeer AH
Clin Exp Rheumatol; 2000; 18(3):391-3. PubMed ID: 10895380
[TBL] [Abstract][Full Text] [Related]
63. [Cardiolipin antibodies in rheumatic polymyalgia and Horton's disease].
Rytikova MI; Bunchuk NV; Kovalev VIu; Nasonov EL
Klin Med (Mosk); 1993; 71(2):33-6. PubMed ID: 8046920
[No Abstract] [Full Text] [Related]
64. CD8+ lymphocyte subset in polymyalgia rheumatica and arteritis temporalis. Inverse relationship between the acute hepatic phase reactants and the CD8+ T-cell subset.
Elling H; Elling P; Olsson A
Clin Exp Rheumatol; 1989; 7(6):627-30. PubMed ID: 2533002
[TBL] [Abstract][Full Text] [Related]
65. [Polymyalgia rheumatica and giant cell arteritis].
Jipp P; Fehring K
Dtsch Med Wochenschr; 1984 Oct; 109(43):1635-8. PubMed ID: 6489177
[TBL] [Abstract][Full Text] [Related]
66. [Glycoregulation disorders in giant-cell arteritis].
Kitschke B; Rodier M; Ciurana AJ; Orsetti A; Mirouze J
Presse Med; 1985 Jun; 14(22):1221-4. PubMed ID: 3160017
[TBL] [Abstract][Full Text] [Related]
67. Measurement of serum levels of dehydroepiandrosterone sulfate: a comparison of radioimmunoassay and enzymatic analysis.
Holtzclaw WD; Gordon GB
Steroids; 1989 Oct; 54(4):355-71. PubMed ID: 2532426
[TBL] [Abstract][Full Text] [Related]
68. In vitro modulatory effect of dehydroepiandrosterone sulfate on apoptosis and expression of apoptosis-related genes in patients with systemic lupus erythematosus.
Yousefi B; Rastin M; Hatef MR; Shariati J; Alimohammadi R; Mahmoudi M
J Cell Physiol; 2019 Aug; 234(8):12676-12684. PubMed ID: 30536399
[TBL] [Abstract][Full Text] [Related]
69. Serum dehydroepiandrosterone sulfate in Alzheimer's disease and in multi-infarct dementia.
Näsman B; Olsson T; Bäckström T; Eriksson S; Grankvist K; Viitanen M; Bucht G
Biol Psychiatry; 1991 Oct; 30(7):684-90. PubMed ID: 1835658
[TBL] [Abstract][Full Text] [Related]
70. A comparative study of platelet reactivity in arthritis.
Riddle JM; Bluhm GB; Pitchford WC; McElroy H; Jimenea C; Leisen J; Venkatasubramanian K
Ann N Y Acad Sci; 1981; 370():22-9. PubMed ID: 6943959
[TBL] [Abstract][Full Text] [Related]
71. Dehydroepiandrosterone sulfate in a long-term care aged population.
Legrain S; Berr C; Frenoy N; Gourlet V; Debuire B; Baulieu EE
Gerontology; 1995; 41(6):343-51. PubMed ID: 8586291
[TBL] [Abstract][Full Text] [Related]
72. Serum dehydroepiandrosterone sulphate (DHEAS) and dehydroepiandrosterone (DHEA) levels in hairy-cell leukaemia.
Demeter J; Fehér T
Eur J Haematol; 1991 Oct; 47(4):313-5. PubMed ID: 1835444
[No Abstract] [Full Text] [Related]
73. Neurosteroids in cerebrospinal fluid in neurologic disorders.
Azuma T; Matsubara T; Shima Y; Haeno S; Fujimoto T; Tone K; Shibata N; Sakoda S
J Neurol Sci; 1993 Dec; 120(1):87-92. PubMed ID: 8289085
[TBL] [Abstract][Full Text] [Related]
74. Dehydroepiandrostenedione sulphate (DHEAS) levels predict high risk of rheumatoid arthritis (RA) in subclinical hypothyroidism.
Shukla R; Ganeshani M; Agarwal M; Jangir R; Kandel G; Sankanagoudar S; Srivastava S
PLoS One; 2021; 16(2):e0246195. PubMed ID: 33592022
[TBL] [Abstract][Full Text] [Related]
75. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II.
Lawrence RC; Felson DT; Helmick CG; Arnold LM; Choi H; Deyo RA; Gabriel S; Hirsch R; Hochberg MC; Hunder GG; Jordan JM; Katz JN; Kremers HM; Wolfe F;
Arthritis Rheum; 2008 Jan; 58(1):26-35. PubMed ID: 18163497
[TBL] [Abstract][Full Text] [Related]
76. MANAGEMENT OF SOME NONARTICULAR RHEUMATIC DISORDERS.
STEINBROCKER O
Mod Treat; 1964 Sep; 1():1254-69. PubMed ID: 14208545
[No Abstract] [Full Text] [Related]
77. Enzymatic determination of dehydroepiandrosterone sulfate in biological fluids.
Chikhaoui Y; Boussioux AM; Nicolas JC; Descomps B; de Paulet AC
J Steroid Biochem; 1983 Sep; 19(3):1319-23. PubMed ID: 6225910
[TBL] [Abstract][Full Text] [Related]
78. Dehydroepiandrosterone sulfate and the risk of myocardial infarction in US male physicians: a prospective study.
Newcomer LM; Manson JE; Barbieri RL; Hennekens CH; Stampfer MJ
Am J Epidemiol; 1994 Nov; 140(10):870-5. PubMed ID: 7977274
[TBL] [Abstract][Full Text] [Related]
79. Factors affecting dehydroepiandrosterone sulphate levels in human breast secretions.
Miller WR; Humeniuk V; Forrest AP
Breast Cancer Res Treat; 1981; 1(3):267-72. PubMed ID: 6216932
[TBL] [Abstract][Full Text] [Related]
80. Influence of intestinal bacterial desulfation on the enterohepatic circulation of dehydroepiandrosterone sulfate.
Van Eldere J; Mertens J; Eyssen H
J Steroid Biochem; 1990 Aug; 36(5):451-6. PubMed ID: 2145475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
